- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.05 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 10 x 2CV: HEGA-10(Non-covalent)
2CV.3: 11 residues within 4Å:- Chain A: P.146, W.151, D.154, E.155, N.174, A.176, Y.177
- Chain B: V.130, T.134
- Ligands: Y01.10, 2CV.16
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:P.146, A:P.146, A:W.151, B:T.134
2CV.4: 5 residues within 4Å:- Chain A: A.197, V.200, L.231, G.235, M.238
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:V.200
2CV.5: 7 residues within 4Å:- Chain A: R.175, V.256, F.257, R.259
- Chain B: L.122, R.127
- Ligands: Y01.10
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Hydrophobic interactions: A:F.257, B:L.122
- Hydrogen bonds: A:R.175, B:R.118, B:R.127
2CV.6: 3 residues within 4Å:- Chain A: V.21, V.268, W.272
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:V.268, A:W.272
2CV.7: 5 residues within 4Å:- Chain A: C.133, W.136
- Chain B: E.155
- Ligands: Y01.2, 2CV.12
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:W.136
2CV.12: 12 residues within 4Å:- Chain A: V.130, T.134, I.138
- Chain B: H.150, W.151, R.153, D.154, E.155, N.174, Y.177, A.180
- Ligands: 2CV.7
6 PLIP interactions:5 interactions with chain B, 1 interactions with chain A- Hydrophobic interactions: B:W.151, B:Y.177, B:A.180, A:I.138
- Hydrogen bonds: B:H.150, B:R.153
2CV.13: 6 residues within 4Å:- Chain B: V.200, Y.201, H.228, L.231, G.235, M.238
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:V.200, B:Y.201
2CV.14: 5 residues within 4Å:- Chain A: L.122, R.127
- Chain B: R.175, F.257
- Ligands: Y01.1
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:R.175, B:R.175
2CV.15: 2 residues within 4Å:- Chain B: L.17, M.18
No protein-ligand interaction detected (PLIP)2CV.16: 7 residues within 4Å:- Chain A: E.155
- Chain B: V.130, C.133, W.136, A.137, A.140
- Ligands: 2CV.3
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:A.137, B:A.140
- Hydrogen bonds: B:K.129
- 2 x 68H: SALBUTAMOL(Non-covalent)
68H.8: 11 residues within 4Å:- Chain A: W.87, D.91, V.92, F.171, S.181, S.185, F.248, F.249, N.252, N.271, Y.275
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:W.87, A:V.92, A:F.171, A:F.248, A:F.248
- Hydrogen bonds: A:S.181, A:S.185, A:N.252, A:N.271, A:Y.275, A:Y.275
- pi-Stacking: A:F.249
68H.17: 13 residues within 4Å:- Chain B: W.87, T.88, D.91, V.92, V.95, F.171, Y.177, S.181, S.185, F.248, F.249, N.271, Y.275
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:W.87, B:T.88, B:V.92, B:V.95, B:F.171, B:F.248
- Hydrogen bonds: B:D.91, B:S.181, B:S.181, B:S.185, B:N.271
- pi-Stacking: B:F.249
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Warne, A. et al., The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor. Nature (2011)
- Release Date
- 2011-01-12
- Peptides
- BETA-1 ADRENERGIC RECEPTOR: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 3.05 Å
- Oligo State
- homo-dimer
- Ligands
- 4 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 10 x 2CV: HEGA-10(Non-covalent)
- 2 x 68H: SALBUTAMOL(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Warne, A. et al., The Structural Basis for Agonist and Partial Agonist Action on a Beta1-Adrenergic Receptor. Nature (2011)
- Release Date
- 2011-01-12
- Peptides
- BETA-1 ADRENERGIC RECEPTOR: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B - Membrane
-
We predict this structure to be a membrane protein.